Research Article

Evolutionary History of the Cancer Immunity Antigen MAGE Gene Family

  • Yukako Katsura,

    Affiliation: Department of Evolutionary Studies of Biosystems, The Graduate University for Advanced Studies (Sokendai), Hayama, Kanagawa, Japan

  • Yoko Satta mail

    Affiliation: Department of Evolutionary Studies of Biosystems, The Graduate University for Advanced Studies (Sokendai), Hayama, Kanagawa, Japan

  • Published: June 10, 2011
  • DOI: 10.1371/journal.pone.0020365


The evolutionary mode of a multi-gene family can change over time, depending on the functional differentiation and local genomic environment of family members. In this study, we demonstrate such a change in the melanoma antigen (MAGE) gene family on the mammalian X chromosome. The MAGE gene family is composed of ten subfamilies that can be categorized into two types. Type I genes are of relatively recent origin, and they encode epitopes for human leukocyte antigen (HLA) in cancer cells. Type II genes are relatively ancient and some of their products are known to be involved in apoptosis or cell proliferation. The evolutionary history of the MAGE gene family can be divided into four phases. In phase I, a single-copy state of an ancestral gene and the evolutionarily conserved mode had lasted until the emergence of eutherian mammals. In phase II, eight subfamily ancestors, with the exception for MAGE-C and MAGE-D subfamilies, were formed via retrotransposition independently. This would coincide with a transposition burst of LINE elements at the eutherian radiation. However, MAGE-C was generated by gene duplication of MAGE-A. Phase III is characterized by extensive gene duplication within each subfamily and in particular the formation of palindromes in the MAGE-A subfamily, which occurred in an ancestor of the Catarrhini. Phase IV is characterized by the decay of a palindrome in most Catarrhini, with the exception of humans. Although the palindrome is truncated by frequent deletions in apes and Old World monkeys, it is retained in humans. Here, we argue that this human-specific retention stems from negative selection acting on MAGE-A genes encoding epitopes of cancer cells, which preserves their ability to bind to highly divergent HLA molecules. These findings are interpreted with consideration of the biological factors shaping recent human MAGE-A genes.


The evolutionary mode of a gene family, namely the process of birth and death of genes and the extents of sequence divergence, depends on the functional divergence of duplicated genes and on the local structure of the genome where the family resides [1], [2]. Here, local structure of the genome refers to tandem or inverted repeats (IRs). The evolution of a gene family on IRs can be particularly complex as a result of homogenization by frequent gene conversion and structural instability such as due to frequent insertions and/or deletions.

Warburton et al. (2004) found a preponderance of large, IRs with a high degree of similarity between repeats on the X and Y chromosomes (~30% of IRs in the human genome are on the X and Y chromosomes) [3]. Many IRs on the X and Y contain genes expressed predominantly in the testis [3]. Warburton and his colleagues suggested that these IRs play an important role in human genome evolution. However, the precise role of IRs in evolution has remained unclear. Therefore, in this study, we attempt to examine the tempo and mode of gene family evolution in IRs, with a specific focus on the melanoma antigen (MAGE) gene family, in which members are located on a large (~100 kb) palindrome on the human X chromosome.

MAGE was originally identified as “a melanoma antigen” and later MAGE and its homologs were discovered to form a multi-gene family in eutherian genomes [4][7]. MAGE homologous sequences have been found in some vertebrates (zebrafish and chicken) [8], [9] and invertebrates (fruit fly) [10]. In the human genome, this family is composed of 10 subfamilies and each subfamily is made up of one to 15 genes [7]. In addition to classification by subfamily, MAGE genes can also be classified into type I or type II, based on their expression patterns and function. Type I genes are composed of three subfamilies (MAGE-A, to –C) and type II genes of seven subfamilies (MAGE-D to -F, -H, -L2, NDN, NDNL2). Type I genes are expressed in highly proliferating cells such as tumors, placenta and germ line cells [4]. Type II genes, by contrast, are ubiquitously expressed in somatic cells, and some type II genes are known to be involved in apoptosis or cell proliferation [11].

All type I MAGE genes are located on the X chromosome and encode tumor antigens that play a key role in cancer immunity. Peptides in the human MAGE homology domain (MHD), which is 160–170 amino acid long, are epitopes for human leukocyte antigen (HLA) class I molecules [4]. When the antigen (peptide in the MHD) on a tumor cell binds to a receptor on a killer T-cell, the T-cell attacks the tumor cell [4], [12]. HLA is exceptionally polymorphic in the human genome and different HLA alleles can bind different epitopes [13], [14]. MAGE genes may encode many epitopes so as to bind to, or react with, every HLA molecule. Thus, it is of interest to trace the origin of the association between HLA and MAGE as well as to determine how the genetic diversity in the epitope-coding region has evolved and been maintained.

Many MAGE genes are thought to be mammalian-specific [7]. In addition, most eutherian MAGE genes have a single exon to encode a protein and therefore they are likely to have derived from retrotransposition of MAGE-D [7], because only MAGE-D subfamily members have 14 exons where an ORF is encoded between the second to 12th exons [15]. Yet, the relationship between type I and type II genes has not been fully investigated and the mode of diversification of these genes remains unclear.

In this study, we investigate the evolutionary history of the MAGE gene family. First, we searched for the most anciently diverged MAGE genes in vertebrate and invertebrate genomes. Second, we investigated how and when ancestors of each three type I and seven type II subfamilies were generated with special reference to their mode of amplification. Third, we focus on the MAGE-A subfamily (one of the type I subfamilies) and demonstrate how the genome arrangement has occurred in primates. Finally, we show that some human MAGE-A genes have undergone negative selection against homogenization by gene conversion in order to retain their genetic variations among amino acid sequences. We suggest that this selection is related to the maintenance of a variety of HLA epitopes in cancer cells.

Materials and Methods

Sequences used

Human (Homo sapiens) nucleotide sequence data and corresponding gene information were obtained from the NCBI database (build 36.3; Syntenic or homologous genomic sequences from other primates and mammals, including opossums (Monodelphis domestica) and platypuses (Ornithorhynchus anatinus), were retrieved from the NCBI and Ensembl databases ( To find conserved synteny between the human X chromosome and chromosomes in other animals, BLAST analyses using human MAGE genes as queries were performed. To identify homologous sequences, we use 70% as a cut-off value for BLAST searches.

Identification of genomic structures

Identification of IRs and tandem repeats was conducted using a dot-matrix approach [16]. GenomeMatcher [17] was then used to obtain detailed information on nucleotide sequence similarity between duplicate units. A diagram drawn by this program depicts the extent of similarity between sequences using color codes, with red representing similarity greater than 95%, orange representing approximately 90%–95%, green representing approximately 85%–90%, and blue representing lower than 85%.

Phylogenetic and molecular evolutionary analyses

To study phylogenetic relationships among MAGE family members, 158 coding sequences (CDSs) in the human, chimpanzee (Pan troglodytes), macaque (Macaca mulatta), mouse (Mus musculus), cow (Bos taurus), dog (Canis lupus), opossum, platypus, chicken (Gallus gallus) and zebrafish (Danio rerio) genome were retrieved from the NCBI database (Table S1). MAGE homologs were also searched in Ensembl database of the western African clawed frog (Xenopus tropicalis), lampreys (Petromyzon marinus), lancelets (Branchiostoma floridae), tunicates (Ciona intestinalis) and sea urchins (Strongylocentrotus purpuratus). For each of these species, we searched for MAGE homologs over the whole genomes. In the searches for homologs, MAGE-D subfamily members were used as a query, because MAGE-D is thought to be the ancestral MAGE subfamily [7]. When we use other human MAGE sequences as a query, we found that sequences detected were already included in the result obtained using MAGE-D.

In the human genome, there were 37 annotated MAGE genes on the X chromosome: 15 MAGE-As, 11 MAGE-Bs, three MAGE-Cs, five MAGE-Ds, two MAGE-Es and one MAGE-H. In addition, two MAGE-Fs are located on chromosome 3, and necdin-like 2 (NDNL2 or MAGE-G), MAGE-like 2 (MAGE-L2) and necdin (NDN) are on chromosome 15. Besides the annotated genes, a homologous sequence (psMAGEA-like: psMAGEAL, NC_000023: 2765558‥ 2770471) corresponding to the human MAGE pseudogene, psMAGEA (NC_000023: complementary 151952946‥151957859), was identified. Gene abbreviations used in this study follow the standards used for human genes.

The sequences obtained were aligned using Clustal W software [18] with manual corrections. The sequences of human MAGE-H, -A5, and mouse -A9 were short. These were discarded because inclusion of these sequences made a meaningful sequence alignment short. The number of nucleotide differences per site (p-distance) was then calculated using MEGA4 [19], and the phylogeny was constructed using the neighbor-joining (NJ) [20] method available in this software. Phylogenies were also constructed with Randomized A(x)ccelerated Maximum Likelihood (RAxML) [21] and Bayesian (Bayes) methods. A program for the RAxML method is provided by and that for the Bayes method is MrBayes 3 [22]. The alignments used here are available upon request. DnaSP v5 [23] was used for the window analysis of nucleotide divergence. RepeatMasker [24] was used to screen sequences for interspersed repeats in the NCBI database. A program, GENECONV [25] was used to detect gene conversion.

Transcription factor binding sites

Transcription factor binding sites (TFBs) were examined using the TRANSFAC R4.3 database [26], available on the TFBIND website ( [27]. To find a candidate TFB, sequences upstream of target genes were aligned, and highly conserved sequences were chosen. The sequences were checked for the presence of TFBs annotated in the database.


Origin of the vertebrate and mammalian MAGE gene family

To identify MAGE homologs in lampreys, lancelets, tunicates, and sea urchins, a BLAST search was performed for their genome and EST sequences, using MAGE-D genes as queries. Although there were no detectable homologous genes in lampreys and sea urchins, hypothetical genes in both tunicates (XM_002119518) and lancelets (XM_002613563) showed 37% sequence similarity with the human MAGE-D1. The BLAST search results indicated that the emergence of MAGE gene could have occurred before the divergence of Protochordata from Chrodata.

In jawed vertebrates, the zebrafish genome possesses a single MAGE gene, Necdin-like 2 (DareNDNL2) [8]. NDNL2 genes are found also in humans, mice and cows, but eutherian NDNL2s are processed genes and have a single exon, whereas DareNDNL2 possesses ~11 exons. A phylogenetic tree based on amino acid sequences shows that eutherian NDNL2s are paraphyletic to DareNDNL2 (Figs. 1 and S1): DareNDNL2 is a “primary” ortholog of eutherian MAGE genes [28]. This phylogenetic relationship (topology of the tree) is also supported by RAxML and Bayes trees (data not shown).


Figure 1. Phylogeny of the MAGE gene family.

CDSs of 158 MAGE genes were used (see Table S1). The CDS compared is 204 bp long. After alignment, all gaps were excluded for tree construction. Subfamily clusters are shown. The number at each node is the bootstrap value supporting the node. Fish NDNL2 (Dare NDNL2) and mammal NDNL2 are shown in blue. Species name abbreviations are as follows: Bota (Bos taraus), Capo (Cavia porcellus), Dare (Danio rerio), Gaga (Gallus gallus), Hosa (Homo sapiens), Mamu (Macaca mulatta), Modo (Monodelphis domestica), Mumu (Mus musculus), Orna (Ornithorhynchus anatinus), and Patr (Pan troglodytes). Figure S1 is an enlarged version of this figure and has legible text.


Each of the frog and chicken genomes possesses only one MAGE gene. In both cases, concerning the syntenic relationship with DareNDNL2, position of the gene on a chromosome could not be confirmed because of the incomplete assignment of genes on chromosomes in these species. However, given that phases at each exon and intron boundary in the CDS of fishes, frogs and chickens were well conserved (Table 1), the single MAGE genes in the frog and chicken are likely to be one-to-one orthologs of DareNDNL2.


Table 1. Phases at exons in the MAGE coding sequence of zebrafish, African clawed frog, chicken and mammals.


Although only a single MAGE was found in fishes, frogs and chickens, humans and mice have multiple subfamilies of MAGE genes [7]. Thus, it is interesting to investigate MAGE homologs in monotremes (platypus) and marsupials (opossum). A full-genome BLAST search using human MAGE-D1 as a query detected one MAGE-like (MAGEL) sequence in the platypus and two MAGELs in the opossum. These were tentatively named OrnaMAGEL and ModoMAGEL1/L2, respectively. BLAST searches using other MAGE genes such as DareNDNL2 as a query resulted in detection of the same genes.

Opossums ModoMAGEL1 and ModoMAGEL2 are located on chromosomes X and 8, respectively. ModoMAGEL2 is coded by a single exon, whereas ModoMAGEL1 is coded by 11 exons. Thus, ModoMAGEL2 is likely to be a processed gene derived from ModoMAGEL1. Indeed, ModoMAGEL1 and ModoMAGEL2 form a monophyly in the tree (Fig. 1, Fig. S1) and in trees constructed by three different methods (NJ, RAxML and Bayes).

The platypuses OrnaMAGEL gene is located on the contig Ultra 403 and consists of 10 exons. Although the number of exons differs from that in ModoMAGEL1, the phases and sizes of shared exons are well conserved (Table 1). Moreover, Ultra 403 also contains the ubiquitin ligase gene HUWE1 (HECT, UBA and WWE domain containing 1), which is located ~600 kb upstream from OrnaMAGEL. An in situ hybridization study confirmed that in the platypus, HUWE1 is located on chromosome 6 [29]; thus, it is likely that this contig is a part of chromosome 6. Platypus chromosome 6 is homologous to the autosomal ancestor of eutherian and marsupial X chromosomes [29]. In fact, the region surrounding OrnaMAGEL on the contig showed a syntenic relationship with the human Xp11 region. In the human genome, the position corresponding to OrnaMAGEL is occupied by MAGE-D2 and -D3 (Fig. 2). Human MAGE-D2 and -D3 possess 13 exons, and the phases and sizes of shared exons are conserved with OrnaMAGEL, as well as with ModoMAGEL1 and other MAGE genes in the chicken, frog, and zebrafish genomes (Table 1).


Figure 2. Synteny between platypus contig Ultra 430 and human X chromosome Xp11.

Red bars indicate MAGE-D or MAGEL genes in the human or platypus, respectively. Black bars and gene names indicate syntenic genes between humans and platypuses. Blue bars and gene names indicate genes that do not show synteny. Other MAGE-D subfamily members, MAGE-D1 and MAGE-D4 are located at 51.6 M and 51.9 M on the human X chromosome, respectively.


Phylogeny of the mammalian MAGE gene family

A tree of human MAGE genes shows that the three type I MAGE subfamilies (MAGE-A, -B and –C) form a monophyletic cluster that is distinct from the seven type II subfamilies (MAGE-D, -E, -F, -H, -L2, NDN and NDNL2) (Fig. 3). The evidence is supported by five phylogenetically informative substitutions (D16Y, K23T, I62V, A113E, and R156Q in an alignment of the MHD, Fig. S3). In addition, MAGE-D genes form a monophyletic cluster. Although the number of nucleotides used in this analysis is small, it is clear that type I subfamilies diverged more recently than type II subfamilies (Fig. 3 and Fig. S2).


Figure 3. Phylogeny of MHD in human MAGE genes.

The tree is based on the number of amino acid differences per site (p-distances). Genes but for DareNDNL2 in the tree are all MAGE genes found in the human genome. DareNDNL2 from zebrafish is used to determine the root of the tree. The number of sites compared is 92 amino acids without gaps. The bootstrap value is indicated at the node. Sequences are listed in Table S1. MAGE-E has duplicated MHD and the duplication has occurred earlier than the emergence of type Ι genes. MAGEE1_1 (MAGEE2_1) and MAGEE1_2 (MAGEE2_2) represent the MHD at the N and C terminal side of MAGE-E1 (MAGE-E2), respectively. The eutherian MAGE-D3 gene encodes trophinin (TRO), which is expressed in the placenta and affects embryo implantation.


With the exception of MAGE-D genes, mammalian MAGE genes have a single exon for CDS. Thus these are likely to be processed genes derived from transcripts of MAGE-D or other MAGE-D processed genes [7], [30]. However, we cannot rule out the possibility that an ancestor of each subfamily resulted from duplication of a processed gene.

To examine how the ancestor of each gene family arose, the nucleotide sequences of a single representatives from each subfamily were compared with one another using dot-matrix analysis [16]. If an entire coding region including flanking region has been duplicated, the dotter analysis shows the similarity beyond the CDS. On the other hand, an ancestor of each subfamily has been generated by retrotransposition, the analysis shows the similarity only in the CDS.

For the most MAGE genes, the dot-matrix analysis revealed that within and between type I and II significant similarities were observed only in CDS regions, suggesting a retrotranspostion. A comparison between MAGE-A and MAGE-C, on the other hand, was an exception. The comparison reveals the similarity beyond the CDS, suggesting the DNA-based gene duplication. However, it might be possible that other subfamilies were also generated by gene duplication. The sequence similarity in flanking regions of duplicates was possibly lost during evolution because of the weaker functional constraint. Indeed, the extent of synonymous sequence divergences among type II gens and those between type I and type II genes ranges from 0.81 to 1.0, such that no significant similarity in a region beyond the CDS was observed. Although cladistic markers such as LINEs might have been informative for distinguishing retrotransposition from gene duplication, no such informative elements were found. Therefore, in the absence of any supportive evidences, we concluded that MAGE-C was duplicated from MAGE-A and that other subfamilies were generated by retrotransposition. In total, eight insertions of retrotransposed MAGE have occurred in the genome of ancestral Eutheria and each processed gene became an ancestor of a subfamily. Following retrotransposition, an independent gene duplication appears to have taken place within each subfamily.

Gene duplication and palindrome formation

It is noteworthy that the clustering pattern of MAGE-A differs from that of MAGE-B (Fig. 1, Fig. S1). Each of the 11 human MAGE-B genes form a monophyletic cluster with orthologs in other eutherians, whereas the 15 MAGE-A genes form species- or taxon-specific clusters (Fig. 1, Fig. S1 and S2). Moreover, three MAGE-C genes appear to be primate-specific. Within the two type II MAGE subfamilies, five MAGE-D and two MAGE-E genes also show a clustering pattern (one-to-one orthologous relationship) similar to that of MAGE-B (Figs. 1 and 3).

A total of 16 MAGE-A genes are located on Xq28, in the region of 148 Mb to 153 Mb, and are clustered into three blocks A, B and C (Fig. 4A). Blocks A and B contain five (MAGE-A11, -A9, -A9B, -A8 and psMAGEA7) and ten (MAGE-A4, -A5, -A10, -A6, -A2B, -A2, -A12, -A3, psMAGEA and psMAGEAL) genes, respectively, whereas block C contains a single gene (MAGE-A1) (Fig. 4B and C). Each of the three blocks possesses a palindrome (Fig. 4C). However, in only block B most genes (six out of ten) are located on both arms of the palindrome (Fig. 4C). Three nearly identical pairs of MAGE-A2/A2B, -A3/A6, psMAGEA/psMAGEAL are located in symmetric positions on the arms (Fig. 4B and 4C), whereas MAGE-A12 is located in the loop region. We designated a pair of duplicate genes or sequences x and y on symmetric positions of the palindrome as x/y. The phylogenetic relationship among 16 MAGE-A genes including psMAGEAL (Fig. 4B, see Materials and Methods) and with MAGE-D used as an outgroup revealed that five genes in block B are in a monophyly, whereas a pair of psMAGEA/psMAGEAL genes are distantly related to other MAGE-A genes.


Figure 4. Genomic structure, palindrome prediction and phylogeny in human MAGE-A genomic region.

(A) A diagonal line drawn from the upper left to the lower right indicates identity within the region. The region is divided into the three subregions, A, B, and C, which contain five, 10 and one MAGE-A genes, respectively. (B) The tree was constructed using the number of nucleotide differences (p-distances) among CDSs (1916 bp) of the 16 MAGE-A genes. The number at each node represents the bootstrap probability supporting that node. Bootstrap values greater than 50% are shown. Operational taxonomic units (OTU) in magenta, green and blue represent genes in subregions A, B and C, respectively. (C) Three predicted palindromes shown in subregions A, B and C. In subregion B, most of genes are located on putative palindrome arms.


Human block B consists of seven duplicate units. Each unit is 10–20 kb long and contains a MAGE-A and a chondrosarcoma associated gene (CSAGE) [31] (Fig. 5A). BLAST analysis of mammalian genomes also shows the absence of CSAGE homologs in non-primate mammals. The palindrome in block B was not observed in non-primate genomes, such as the mouse, dog and horse genomes.


Figure 5. Genomic structures, phylogeny and predicted palindromes in subregion B.

(A) The diagonal lines from the left top to the right bottom indicates identity within the human (left panel) or the macaque (right panel) sequence. Gaps in the diagonal line in the macaque indicate sequencing gaps. The colored boxes at the bottom of each panel indicate seven duplicated units. The same colored boxes within a species indicate that they are more closely related to each other than to others, whereas those between species indicate putative orthologs. (B) Palindromes predicted in subregion B of the human (left) or the macaque (right) sequence. Numbers beside the lines indicate each duplicated unit. (C) An NJ tree based on p-distances between duplicated units (2880 bp) is shown. The color-code for OTU is the same as in (A) and (B).


Among primates, block B can be identified in macaques (Fig. 5A). This block also contains seven duplicated units, but the form of the expected palindrome differs between the human and macaque. Unlike the long stem and short loop observed in the human, in the macaque, a short stem and a large loop structure is predicted (Fig. 5B). Further, the orthology of units between macaques and humans is curious given their positions. For convenience, we designated the seven duplicated units in block B as h1 to h7 in humans and m1 to m7 in macaques (Fig. 5A) and then examined their phylogenetic relationships (Fig. 5C). Units of h1/h7 harboring psMAGEAL and psMAGEA genes are orthologous to m1/m7. Units of h3/h5 with MAGE-A2/A2B genes are orthologous to m5 with MAGE-A2: however, in macaques, m5 is located in the loop and there is no partner (a highly similar sequence) of m5 in the block. The unit of h4 with MAGE-A12 is orthologous to m3, but in macaques this unit does not contain a MAGE gene (Fig. 5A). Furthermore, the relationships among h2/h6, m2, m4 and m6 are somewhat confusing, despite the fact that the MAEG-A3/A6 is in the h2/h6 and three possible homologs (MAGE-A3, -3L, and –A3L) are in m2, m4 and m6. The p-distance between h2 and h6 was 0.7% (±0.2), whereas the p-distances among m2, m4 and m6 are much greater (12.1%) than the former. The pairwise distances of units between humans and macaques ranged from 8.3% (±0.5) to 17.7% (±0.7), which is too large for an orthologous relationship. The phylogeny also did not support an orthologous relationship among each of the three units in macaques (m2, m4, or m6) and h2/h6 (Fig. 5C).

To further examine the orthologous relationships of these duplicated units, cladistic markers such as SINEs and LINEs were sought using RepeatMasker software [24] (Fig. 6). In general, the arrangement of SINEs, LINEs, LTRs, and short repeats in block B shows partial similarity between the human and macaque genome. The position and type of repetitive sequences found across the entire m2 region are almost identical to those found in the distal half of h2. A similar distribution of repetitive sequences is observed between a region of m5 and h5, and the similarity is also observed between a part of m4 and that of h4. However, species-specific regions seem to be present in each genome. In humans, the region is ~40 kb long and extends from the middle of h2 to h4, while in macaques, the species-specific region is ~30 kb and extends from the middle of m2 to m4. Unlike results of the phylogeny and genetic distance analyses (Figs. 5C and 6), the cladistic markers showed that h2 with human MAGE-A6 and m2 with the macaque MAGE3L are indeed orthologous to each other.


Figure 6. Maps of cladistic markers in humans and macaques.

Colored triangles show interspersed elements (LINEs or SINEs), LTRs, DNA transposons (DNA-TP) or simple repeats (SR) found in the human or macaque genome, respectively. Brackets under each line indicate duplicated units. Light pink arrows indicate palindrome structure. The light blue arrow indicates sequencing gaps in macaques. Letters a to l and a′ to i′ on the triangles indicate orthologous insertion elements in the human and macaque genomes. The light green bar indicates a human- or macaque-specific region and dotted lines indicate the boundary between species-specific and orthologous regions.


Human-specific palindrome and gene conversion

The dot-matrix analysis revealed that the palindrome in block B is apparent only in humans. Although sequencing gaps currently exist in the chimpanzee and orangutan genome, the available sequences showed that the palindrome in block B is less apparent in these two apes than in humans (Fig. 7). We parsimoniously inferred the ancestral state of the palindrome by using sequence information of the genome of extant primate species.


Figure 7. Window analysis of nucleotide divergence between a pair of palindrome arms in the human genome.

The window size is 500 bp with no overlap between adjacent windows. Colored rectangles at the bottom of the figure indicate the duplicated unit including the MAGE genes (light pink arrows). The ordinate represents nucleotide divergence (d) and the abscissa represents position (in bp) relative to the center of the loop (position zero, blue arrow). The area surrounding a red dotted line indicate the high diverged region in MAGE-A3 and MAGE-A6.


Genes on palindromes may experience frequent gene conversion. Indeed, a window analysis of 500 bp with a non-overlapping interval reveals that sequences of palindrome in arms are almost identical (Fig. 8). Furthermore, analysis with a program GENECONV also revealed a possible gene conversion in the majority of palindrome arms. However, in the middle of h2 and h6, there is a region with significantly large sequence divergence (p = ~2%, P<0.001) compared with the neighborhood (Fig. 8). The highly diverged region corresponds to a 673 bp of the 5′ ends of the MAGE-A3/A6 sequences. MAGE-A3/A6 encode epitopes for HLA class I molecules in tumor cells and for epitopes for HLA class II molecules in melanoma cells [32][34]. The distribution of these epitopes in type I MAGE genes (Fig. S4) reveals that epitope-coding is confined to this highly diverged region (Fig. S4). In fact, among 13 amino acid changes between MAGE-A3 and -A6, 10 substitutions are concentrated in this epitope-coding region. Both MAGE-A3 and -A6 can thus produce various epitopes for many kinds of HLA molecules (Fig. S4).


Figure 8. The phylogeny of six MAGE-A genes from humans and macaques.

The NJ tree was based on synonymous divergences among six MAGE-A CDSs. The number of sites compared is 314. The root is determined by MAGE-A4.



The ancient origin of MAGE genes (phase I)

The search for a MAGE gene in invertebrate genomes has revealed the presence of homologs in the tunicate and the lancelet genomes. MAGE-like genes containing the conserved MHD sequence have also been reported in insects [9], [10]. The MAGE gene in the fruit fly (Drosophila melanogaster: DrmeMAGE) plays a key role in neurogenesis [35]. The gene lacks an intron and therefore might be a processed gene. We searched for a DrmeMAGE-related gene with introns in the FlyBase data (, but no candidate gene was detected. We also carried out a TBLASTN search for a DrmeMAGE homolog with introns over the entire NCBI database. We found that the MHD in DrmeMAGE has nearly 30% similarity with MHD in vertebrate MAGE genes, and that the amino acid sequence of the epitope-coding region in the human MAGE-B16 (FLWGPRAKAE) [10] is completely conserved. However, DrmeMAGE is not expressed in tumor cells and it does not code for antigens in the fly. MAGE homologs were also found in the Arabidopsis thaliana genome. A. thaliana MAGE shares 25% similarity with human MAGE-A8 but the function of the MAGE-related gene is not known. Since our study showed that the MAGE-A and -B subfamilies diverged in eutherians, MAGE-like sequences in insects and plants have originated independently from eutherian MAGE-A and -B sequences and the extent of sequence similarity between MAGE genes in eutherians and in plants or insects might be due to functional convergence.

The synteny (Fig. 2) and the conservation of phases in exons (Table 1) reveal that OrnaMAGEL is an ortholog of MAGE-D2 or -D3 in humans. An ancestral MAGE gene probably had been a single copy until the divergence of monotremes and therians. Moreover, in the stem lineage of mammals, the ancestral MAGE was located on an autosome that later differentiated into a sex chromosome. Thus, the MAGE gene presumably become X-linked in marsupials and eutherians, and differentiated into MAGE-D in extant eutherians. The eutherian MAGE-D3 gene encoding trophinin (TRO) is expressed in the placenta and affects embryo implantation [36], suggesting that MAGE-D3 evolved its current function specifically in eutherians.

Since the ancestral MAGE gene was on the proto-X chromosome, the gene may have a homolog on the extant Y chromosome. This is because both sex chromosomes are thought to have derived from a pair of autosomes. However, we found no MAGE homolog on the Y chromosome of humans or other eutherians. The region syntenic to human Xp11 is located near the tip of the opossum X chromosome. However, in many eutherians the regions syntenic to human Xp11 are located near the centromere of the X chromosome. The ancestral region appears to have moved towards the centromere before the radiation of eutherians. This transposition on the X chromosome may have prevented pairing with the Y chromosome, leading to loss of MAGE from the Y chromosome.

Formation of ancestors of multi-gene families by retrotransposition (phase II)

In eutherians, the MAGE gene family can be divided into 10 subfamilies. Nine of these subfamilies, all but MAGE-D, are processed genes and then ancestors of eight subfamilies, all but MAGE-D and MAGE-C, appear to have been generated via retrotransposition. The source of the retrotransposed genes has been thought to be MAGE-D [7]. We attempted to conform both the source of these genes and their order of emergence using the extent of similarity among the CDSs of MAGE genes. However, the stretches of sequences with significant similarity were too short to make conclusion about the ancestry of processed genes.

At least eight times of retrotransposition may have been necessary to produce ancestors of each of the eight extant MAGE subfamilies at the early stage of eutherian evolution. The activation of reverse transcriptase necessary for this transposition might have been provided by the activation of LINE elements at that time [37].

To be functional, any processed gene should gain promoter activity near the insertion site. MAGE-A, -B, and -C are all expressed in cancer cells and in the testis. Sequence similarity beyond the CDS shows that MAGE-A and MAGE-C were produced by gene duplication. In addition, the tumor types in which MAGE-A is expressed are similar to those in which MAGE-C is expressed, but different from those in which MAGE-B genes are expressed [15], [38], [39]. Based on the similar pattern between MAGE-A and MAGE-C gene expression, conserved TFB sequences are expected in the upstream region of MAGE-A and –C. Indeed, in the ~400 bp upstream of ATG, MAGE-A and -C have potential TFBs in common. Among several such TFBs, STAT (signal transducers and activators of transcription) binding site (TTCCCRKAA) and LYF (lymphoid transcription factor) binding site (TTTGGGAGR) are found. These sequences are known to act in cancer cells [40], [41].

Gene duplication and palindrome formation (phase III)

The high sequence similarity over the flanking region including possible regulatory elements and the monophyly of MAGE-A genes in the phylogeny (Figs. 1 and 3) suggest that MAGE-A subfamily members most likely originated from gene duplication. Nucleotide divergences among MAGE-A genes (10 to 15%) show that most MAGE-A genes emerged in the stem lineage of Catarrhini or even earlier. Thus we reasoned that orthologs of MAGE-A genes might be present in New World monkeys as well. A database search for such homologs revealed three sequences on contigs 7129, 6382 and 5036 in the common marmoset genome (Callithrix jacchus, UCSC WUSTL version Callithrix jacchus-2.0.2) with greater than 80% similarity to MAGE-A2/A2B, A3/A6 and -A12. Moreover, three additional sequences on contig 880 and one sequence on contigs 1178 and 6382 also show 76–79% similarity to several human MAGE genes. Thus, a total of eight MAGE-A homologs were detected in the common marmoset genome. Although the genomic locations of these homologs are not yet known, their presence is consistent with the idea that the duplication that produced a set of MAGE-A genes probably took place in the stem lineage of simian primates.

It is worth noting that large palindromes on the Y chromosome have also been generated in the stem lineage of the Catarrhini or even earlier [42]. The eight palindromes on the human Y chromosome contain seven gene families. Although nucleotide sequences in symmetrical positions on the palindromic arms are nearly identical, gene family members in asymmetric positions show nucleotide divergences ranging from 5.9 (±1.0) to 13.9% (±1.5). This range is similar to those observed between duplicated units in humans or macaques on the X chromosome, suggesting that simultaneous gene duplication on the X and Y chromosome may have occurred.

The phylogeny of the CDSs of human MAGE-A3/A6 and macaque MAGE-A3, -3L, and -A3L genes indicates that they diverged in the stem lineage of the Catarrhini (Fig. 8), yet their synonymous nucleotide differences are exceptionally high (p = 13.4% (±2.2), Table S2). As is often observed in newly duplicated genes, the degree of functional constraint may change and permit frequent substitutions in CpG dinucleotides. This appears to have happened in the present case as well. Among 315 codons in these MAGE genes, 45 codons contain CpG sites. If the latter codons are excluded, synonymous divergence decreases between human MAGE-A3 or -A6 and macaque MAGE-A3, -3L or -A3L to 7.8% (±2.1) (Table S2, ranging from 6.4% (±1.8) to 9.3% (±2.4)), which is not significantly different from the overall average divergence between human and macaque X chromosomal genes (5.5% (±0.3)) [43]. These results confirm orthology among human MAGE-A3/-A6 and macaque -A3, -3L, and -A3L genes. Importantly, the analysis of syntenic LINE and SINE insertions also clearly indicates one-to-one orthology between MAGE-3L in macaques and MAGE-A6 in humans (Fig. 6).

Human specificity in a palindrome (phase IV)

The overall sequence divergences among orthologous duplicated units in humans and macaques exceed 10%. Since both humans and macaques have seven units of duplicates, it is assumed that five pairs of duplicated units already formed a palindrome in the ancestral genome (Fig. 9). Under this assumption, the present arrangement of duplicated units suggests species- or lineage-specific deletions in a loop region of the palindrome (Fig. 9).


Figure 9. Inferred rearrangements in primate MAGE-A genomic subregion B.

A schematic diagram of duplicated units containing MAGE-A genes in an ancestral and extant species is shown. Each colored box indicates a different duplicated unit as in Fig. 5A. Gray bars indicate sequencing gaps. Colored triangles indicate independent deletions. The same colored triangle in chimpanzees and humans indicates that the deletion occurred in an ancestral species. An arrowhead in each rectangle indicatte the direction of the fragment.


Further examination of nucleotide divergence between the palindromic arms in humans reveals the presence of a significantly diverged region in the middle of MAGE-A3 and -A6 (Fig. 7). Four synonymous substitutions have accumulated exclusively at CpG sites between MAGE-A3 and -A6, and 22 synonymous substitutions differentiate the human MAGE-A6 from the macaque MAGE-3L. If these 22 substitutions have accumulated over the period of 35 million years (myr) of divergence between the two species [44][46], then the accumulation of four substitutions corresponds to 6.4 myr (35 myr×4/22). This suggests that the divergence between MAGE-A3 and -A6 in humans occurred when humans diverged from chimpanzees (~6 to 7 MYA) [47]. Although a one-to-one ortholog of human MAGE-A6 have not been identified in the chimpanzee genome, chimpanzee MAGE3 (a one-to-one ortholog to human MAGE-A3) apparently encodes a lower variety of epitopes than the human ortholog (Fig. S4). In chimpanzees, MAGE3 is indeed truncated in is CDS. Thus, it is likely that the nucleotide differences between MAGE-A3 and -A6 have accumulated specifically in humans.

These findings lead to questions about the evolutionary forces maintaining the diversity observed in human MAGE-A3 and -A6. Considering the role of MAGE-A proteins in cancer immunity [4], a diversity of epitopes might be advantageous. MAGE-A must encode variable epitopes to maintain their ability to bind to HLA molecules. Two alternative mechanisms for generating diversity can be considered: Darwinian selection elevating nonsynonymous substitutions or negative selection against homogenization by gene conversion. Darwinian selection might operate on this epitope-encoding region to enhance the accumulation of mutations.

To know whether Darwinian or negative selection operates we examined the relative rates of nucleotide substitutions in MAGE-A3 and -A6 and their flanking region using the MAGE-A2 sequence as a reference. If Darwinian selection operates in the epitope-coding region, then nucleotide divergence in the epitope-coding region with being compared to A2 should be higher than in the remaining non epitope-coding region. However, we found that the substitution rate is not higher at nonsynonymous sites in the epitope-coding region between -A2 vs. -A3 and -A2 vs. -A6 than at those in the non epitope-coding region. The same result was obtained using different MAGE-A genes as references. Thus, we conclude that the divergence between MAGE-A3 and -A6 was not generated by an elevated nonsynonymous substitution rate. This is also supported by the ratio of nonsynonymous to synonymous divergences between MAGE-A3 and -A6 (dN/dS = 0.9, P<0.001, H0: dN = dS). Rather highly diverged epitopes between -A3 and -A6 indicate negative (purifying) selection against homogenization by gene conversion. A similar effect of negative selection has been observed in immunoglobulin genes [2].

Co-evolution between HLA and MAGE epitopes

Evoking negative selection strongly argues for co-evolution between HLA and MAGE-A3 or -A6. A variety of epitopes must be present in each a MAGE protein, because HLA is extraordinary polymorphic and the HLA and MAGE genes are located on different chromosomes; They are in unlinked status. Because of this unlinked status, it would be difficult for MAGE to be polymorphic in order to associate with HLA.

MAGE-A3 and -A6 encode seven different kinds of epitopes to bind seven different HLA class I molecules: HLA-A1, -A24, -A2, -B37, -B52, -B44, and -B35 molecule. Curiously, however, in macaques there are no corresponding allelic lineages producing the seven major histocompatibility complex (MHC: HLA homologs in macaques) molecules (data not shown). Thus, the association between MAGE and MHC in macaques might be different from those observed in humans. This evolutionary mode of primate MAGE-A genes may be associated with rapid turnover of HLA class I loci in the primates [48]. In addition, among epitope-coding MAGEs, MAGE-A3 and -A6 are unique in that they are highly expressed in tumor cells and encode the highest number of identified epitopes in a gene [32], This might explain reasons why negative selection against gene conversion appears to have operated on only MAGE-A3 and -A6.

The human-specific genetic diversification between MAGE-A3 and -A6 on the palindrome may be associated with human evolution. After diverging from chimpanzees, human ancestors were still arboreal. Subsequently, these ancestors left the forests to live in the savanna and later they lost their fur. This change in habitat likely resulted in direct exposure of the naked skin to strong ultra-violet light. Such exposure is known to increase the risk of tumors such as melanoma. As a means of protection against tumor progression, it is reasonable to imagine that various MAGE-A3 and -A6 genes would be favored by natural selection, facilitating HLA-mediated immunity.

Unique mode of evolution in the MAGE gene family

In the human genome, there are many gene families that appear to have been generated by gene duplication and retrotransposition. Well-known examples of the former case include a set of genes for ribosomal RNAs [49], [50], and those for alpha and beta hemoglobins [51], [52]. In the case of ribosomal RNAs, the requirement for a large amount of the gene products causes the multiplication and homogenization of duplicated units. On the other hand, sequence divergence among members in the hemoglobin gene family depends on the requirement for physiological differentiation of proteins. This kind of functional diversification in a multi-gene family is quite common.

As discussed here, the multiplication of MAGE genes appears to have been mediated by both retrotransposition and gene duplication. Some members of the family have been homogenized by gene conversion, whereas others have evolved against it. The evolutionary mode appears to be determined by genomic environments such as palindrome formation, as well as by functional differentiation, such as to generate a variety of epitopes related to cancer immunity.

Supporting Information

Figure S1.

Enlarged version of Figure 1.



Figure S2.

Schematic representation of the MAGE gene family diversification history. Each triangle indicates a subtree of the depicted subfamily. Numbers at the branch nodes indicate bootstrap values. Branch lengths are arbitrary and do not reflect evolutionary distances.



Figure S3.

The MHD amino acid sequence alignment in human MAGE genes. A dot (.) indicates that an amino acid residue is the same as that in the top line. A dash (-) indicates a deletion of the residue at that position. Red characters indicate amino acid substitutions supporting a monophyletic relationship of MAGE-A, -B and -C (see text) [53][68].



Figure S4.

An alignment of primate MAGE-A amino acid sequences for an epitope coding region. In humans, based on references (1–16), MAGE-A epitopes for HLA alleles are denoted by squares (magenta; HLC class Ι, light blue; HLA class II). HLA alleles that recognize each epitope are indicated in parallel below. Among 13 amino acid substitutions between MAGE-A3 and -A6, 11 substitutions marked by stars occur in the alignment whereas two substitutions (P303L, A308V) occured outside of the region. Among the 11 substitutions, ten that contribute to the production of epitopes for different HLA alleles (E115K, D156L, L175V, T199A, L201F, V205I, K211R, D249H/D249Y, L279V/L279I, H298R) are indicated by green stars. The other substitution within this region (indicated by a blue star; F239L) does not contribute to the production of epitopes of MAGE-A3 and -A6 [53–68].



Table S1.

Accession numbers of nulceotide sequences used in this study. Species names are shown in colored cells.



Table S2.

Nucleotide divergence among six MAGE-A genes from humans and macaques. Synonymous nucleotide divergences (below diagonal) and synonymous nucleotide divergences with removal of CG codons (upper diagonal) for the six MAGE-A genes were showed. Standard errors are provided in parentheses. Sequences are from humans (Hosa) and macaques (Mamu). The number of synonymous sites with CG codons is 226 and that without CG codons is 173.




We thank Dr. Naoyuki Takahata for valuable discussions and for his critical reading of this manuscript. We also thank two anonymous reviewers for their comments.

Author Contributions

Conceived and designed the experiments: YK YS. Performed the experiments: YK YS. Analyzed the data: YK YS. Contributed reagents/materials/analysis tools: YK YS. Wrote the paper: YK YS.


  1. 1. Nei M, Gu X, Sitnikova T (1997) Evolution by the birth-and-death process in multigene families of the vertebrate immune system. Proc Natl Acad Sci USA 94: 7799–7806.
  2. 2. Nei M, Rooney A (2005) Concerted and birth-and-death evolution of multigene families. Annu Rev Genet 39: 121–152.
  3. 3. Warburton PE, Giordano J, Cheung F, Gelfand Y, Beoson G (2004) Inverted repeat structure of the human genome: The X-chromosome contains a preponderance of large, highly homologous inverted repeats that contain testes genes. Genome Res 14: 1861–1869.
  4. 4. van der Bruggen P, Traversari C, Chomez P, Lurquin C, Plaen ED, et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643–1647.
  5. 5. Kirkin AF, Dzhandzhugazyan K, Zeuthen J (1998) The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes. Exp Clin Immunogenet 15: 19–32.
  6. 6. Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N, et al. (2000) T-cell recognition of melanoma-associated antigens. J Cell Physiol 182: 323–31.
  7. 7. Chomez P, Backer OD, Bertrand M, De Plaen E, Boon T, et al. (2001) An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61: 5544–5551.
  8. 8. Bischof J, Ekker M, Wevrick R (2003) A MAGE/NDN-like gene in zebrafish. Dev Dyn 228: 475–479.
  9. 9. López-Sánchez N, González-Fernández Z, Niinobe M, Yoshikawa K, Frade J (2007) Single mage gene in the chicken genome encodes CMage, a protein with functional similarities to mammalian type II Mage proteins. Physiol Genomics 30: 156–171.
  10. 10. Põld M, Põld A, Ma HJ, Sjak-Shie NN, Vescio RA, et al. (2000) Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution. Dev Comp Immunol 24: 719–731.
  11. 11. Bertrand M, Huijbers I, Chomez P, De Backer O (2004) Comparative expression analysis of the MAGED genes during embryogenesis and brain development. Dev Dyn 230: 325–334.
  12. 12. Klein J, Horejsí V (1997) Immunology. Oxford: Blackwell Science. 722 p.
  13. 13. Rammensee H, Falk K, Rötzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11: 213–244.
  14. 14. Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, et al. (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55: 797–810.
  15. 15. Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, et al. (1998) Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 58: 743–752.
  16. 16. Sonnhammer E, Durbin R (1995) A dot-matrix program with dynamic threshold control suited for genomic DNA and protein sequence analysis. Gene 167: GC1–10.
  17. 17. Ohtsubo Y, Ikeda-Ohtsubo W, Nagata Y, Tsuda M (2008) GenomeMatcher: A graphical user interface for DNA sequence comparison. BMC Bioinformatics 9: 376.
  18. 18. Thompson J, Higgins D, Gibson T (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673–4680.
  19. 19. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
  20. 20. Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406–425.
  21. 21. Stamatakis A, Ludwig T, Meier H (2005) RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456–463.
  22. 22. Ronquist F, Huelsenbeck JP, van der Mark P (2005) MrBayes 3.1. MrBayes website. Available: Accessed 2011 May 7.
  23. 23. Librado P, Rozas J (2009) DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 25: 1451–1452.
  24. 24. Smit AFA (1996) Origin of interspersed repeats in the human genome. Curr Opin Genet Devel 6: 743–749.
  25. 25. Sawyer S (1989) Statistical tests for detecting gene conversion. Mol Biol Evol 6: 526–538.
  26. 26. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, et al. (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362–367.
  27. 27. Tsunoda T, Takagi T (1999) Estimating transcription factor bindability on DNA. Bioinformatics 15: 622–630.
  28. 28. Han MV, Hahn MW (2009) Identifying parent-daughter relationships among duplicated genes. Pac Symp Biocomput 114–125.
  29. 29. Delbridge M, Patel H, Waters P, McMillan D, Marshall Graves J (2009) Does the human X contain a third evolutionary block? Origin of genes on human Xp11 and Xq28. Genome Res 19: 1350–1360.
  30. 30. Artamonova II, Gelfand MS (2004) Evolution of the exon-intron structure and alternative splicing of the MAGE-A family of Cancer/Testis Antigens. J Mol Evol 59: 620–631.
  31. 31. Lin C, Mak S, Meitner PA, Wolf JM, Bluman EM, et al. (2002) Cancer/testis antigen CSAGE is currently expressed with MAGE in chondrosarcoma. Gene 1–2: 269–278.
  32. 32. van der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, et al. (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188: 51–64.
  33. 33. Marsman M, Jordens I, Griekspoor A, Neefjes J (2005) Chaperoning antigen presentation by MHC class II molecules and their role in oncogenesis. Adv Cancer Res 93: 129–158.
  34. 34. Crotzer VL, Blum JS (2009) Autophagy and its role in MHC-mediated antigen presentation. J Immunol 182: 3335–3341.
  35. 35. Nishimura I, Sakoda J, Yoshikawa K (2008) Drosophila MAGE controls neural precursor proliferation in postembryonic neurogenesis. Neuroscience 154: 572–581.
  36. 36. Sugihara K, Sugiyama D, Byrne J, Wolf DP, Lowitz KP, et al. (2007) Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation. Proc Natl Acad Sci USA 104: 3799–3804.
  37. 37. Kim T-M, Hong S-J, Rhyu M-G (2004) Periodic explosive expansion of human retroelements associated with the evolution of the hominoid primates. J Korean Med Sci 19: 177–185.
  38. 38. Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, et al. (1997) Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46: 397–408.
  39. 39. Caballero O, Chen Y (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100: 2014–2021.
  40. 40. Yu C, Meyer DJ, Campbell GS, Larmer AC, Carter-Su C, et al. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81–83.
  41. 41. Winandy S, Wu P, Georgopoulos K (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83: 289–299.
  42. 42. Bhowmick B, Satta Y, Takahata N (2007) The origin and evolution of human ampliconic gene families and ampliconic structure. Genome Res 17: 441–450.
  43. 43. Elango N, Lee J, Peng Z, Loh Y, Yi S (2009) Evolutionary rate variation in Old World monkeys. Biol Lett 5: 405–408.
  44. 44. Takahata N (2001) Humanity from African Naissance to Coming Millennia. Tobias PV, Raath MA, Moggi-Cecchi J, Doyle GA, editors. Johannesburg: Firenze University Press, Firenze/ Witwatersrand University Press. pp. 299–305.
  45. 45. Hasegawa M, Thorne J, Kishino H (2003) Time scale of eutherian evolution estimated without assuming a constant rate of molecular evolution. Genes Genet Syst 78: 267–283.
  46. 46. Satta Y, Hickerson M, Watanabe H, O'hUigin C, Klein J (2004) Ancestral population sizes and species divergence times in the primate lineage on the basis of intron and BAC end sequences. J Mol Evol 59: 478–487.
  47. 47. Brunet M, Guy F, Pilbeam D, Mackaye HT, Likius A, et al. (2002) A new hominid from the Upper Miocene of Chad, Central Africa. Nature 418: 145–151.
  48. 48. Sawai H, Kawamoto Y, Takahata N, Satta Y (2004) Evolutionary relationships of major histocompatibility complex class I genes in simian primates. Genetics 166: 1897–1907.
  49. 49. Fedoroff NV (1979) On spacers. Cell 16: 697–710.
  50. 50. Eickbush TH, Eickbush DG (2007) Finely orchestrated movements: evolution of the ribosomal RNA genes. Genetics 175: 477–485.
  51. 51. Fritsch EF, Lawn RM, Maniatis T (1980) Molecular Cloning and Characterization of the Human /b-Like Globin Gene Cluster. Ceil 19: 959–972.
  52. 52. Czelusniak J, Goodman M, Hewett-Emmett D, Weiss ML, Venta PJ, et al. (1982) Phylogenetic origins and adaptive evolution of avian and mammalian hemoglobin genes. Nature 298: 297–300.
  53. 53. Pold M, Pold A, Ma HJ, Sjak-Shieb NN, Vescio RA, et al. (2000) Cloning of the first invertebrate MAGE paralogue: an epitope that activates T-cells in humans is highly conserved in evolution. Dev Comp Immunol 24: 719–731.
  54. 54. Bredenbeck A, Losch FO, Sharav T, Eichler-Mertens M, Filter M, et al. (2005) Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy. J Immunol 174: 6716–6724.
  55. 55. Chianese-Bullock KA, Pressley J, Garbee D, Hibbitts S, Murphy C, et al. (2005) MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanoma. J Immunol 174: 3080–3086.
  56. 56. Celis E, Tsai V, Crimi C, DeMars R, Wentworth PA, et al. (1994) Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci U S A 91: 2105–2109.
  57. 57. Hillig R, Coulie PG, Stroobant V, Saenger W, Ziegler A, et al. (2001) High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene. J Mol Biol 310: 1167–1176.
  58. 58. Marturano J, Longhi R, Casorati G, Protti M (2008) MAGE-A3(161–175) contains an HLA-DRbeta4 restricted natural epitope poorly formed through indirect presentation by dendritic cells. Cancer Immunol Immunother 57: 207–215.
  59. 59. Graff-Dubois S, Faure O, Gross DA, Alves P, Scardino A, et al. (2002) Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: implication in a broad-spectrum tumor immunotherapy. J Immunol 169: 575–580.
  60. 60. Miyahara Y, Naota H, Wang L, Hiasa A, Goto M, et al. (2005) Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE. Clin Cancer Res 11: 5581–5589.
  61. 61. Gotoh M, Takasu H, Harada K, Yamaoka T (2002) Development of HLA-A2402/K(b) transgenic mice. Int J Cancer 100: 565–570.
  62. 62. Groeper C, Gambazzi F, Zajac P, Bubendorf L, Adamina M, et al. (2007) Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer. Int J Cancer 120: 337–343.
  63. 63. Novellino L, Castelli C, Parmiani G (2005) A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol Immunother 54: 187–207.
  64. 64. Luescher I, Romero P, Kuznetsov D, Rimoldi D, Coulie P, et al. (1996) HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44. J Biol Chem 271: 12463–12471.
  65. 65. Escudier B, Dorval T, Chaput N, André F, Caby MP, et al. (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med 3: 10.
  66. 66. Vujanovic L, Mandic M, Olson W, Kirkwood J, Storkus W (2007) A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6. Clin Cancer Res 13: 6796–6806.
  67. 67. Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, et al. (2003) MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. Clin Cancer Res 9: 947–954.
  68. 68. Wang X, Cohen WM, Castelli FA, Almunia C, Lethé B, et al. (2007) Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family. Cancer Immunol Immunother 56: 807–818.